Stilla Technologies
Stilla Technologies is a life-sciences instrumentation company that develops digital PCR (dPCR) systems, consumables, and assays, best known for its Naica system for Crystal Digital PCR and the Nio product line. With operations in France and the United States, its technology serves oncology diagnostics, cell and gene therapy, and infectious-disease testing. Stilla was acquired by Bio-Rad Laboratories (announced February 2025, ~$225M plus up to $50M in milestones, closed 2025); its web properties now redirect to Bio-Rad. The company operates laboratory hardware and consumables rather than a public developer platform — no OpenAPI, developer portal, SDKs, CLI, or MCP surface was found during enrichment.
Stilla Technologies is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Life Sciences, Diagnostics, and Digital PCR.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API